
Join to view full profile
Seattle Cancer Care Alliance825 Eastlake Ave EastSeattle, WA 98109
Phone+1 206-606-4051
Dr. Ghiuzeli is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Cristina Maria Ghiuzeli is an hematologist at SCCA (Seattle Cancer Care Alliance) in Seattle, Washington. She specializes in treatment of myeloid malignancies (acute myeloid leukemia, MDS, aplastic anemia, and myeloproliferative neoplasms) and acute lymphoblastic leukemia.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2006 - 2009
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 2003 - 2006
Albert Einstein College of MedicineClass of 2003
Certifications & Licensure
WA State Medical License 2020 - 2027
NY State Medical License 2006 - 2021
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR (Complete), Allscripts, 2016-2017
Clinical Trials
- Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia Start of enrollment: 2008 Jan 15
- Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma Start of enrollment: 2011 Apr 28
Publications & Presentations
PubMed
- 3 citationsHyper-CVAD versus dose-adjusted EPOCH as initial treatment for adults with acute lymphoblastic leukemia.Lucas C Zarling, Philip A Stevenson, Lorinda A Soma, Christen H Martino, Mary-Elizabeth M Percival
European Journal of Haematology. 2023-12-01 - 7 citationsPhase 1/2 study of sorafenib added to cladribine, high-dose cytarabine, G-CSF, and mitoxantrone in untreated AML.Anna B Halpern, Eduardo Rodríguez-Arbolí, Megan Othus, Kelsey-Leigh A Garcia, Mary-Elizabeth M Percival
Blood Advances. 2023-09-12 - 12 citationsSuccessful Treatment of Persistent Symptomatic Coronavirus Disease 19 Infection With Extended-Duration Nirmatrelvir-Ritonavir Among Outpatients With Hematologic Cancer.Catherine Liu, Leah H Yoke, Pooja Bhattacharyya, Ryan D Cassaday, Guang-Shing Cheng
Open Forum Infectious Diseases. 2023-06-01
Press Mentions
Tip Sheet: Funding Awarded to Two Ovarian Cancer Research Projects, Progress Towards Liquid Biopsies for Lung Cancer — and Cannabis and Alcohol Use in PatientsMay 3rd, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: